EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value
1. Vivani Medical plans to spin off Cortigent as a public company. 2. Growth in the neurostimulation market is driven by chronic disease prevalence. 3. Cortigent develops brain implants for vision restoration and motor recovery. 4. The spin-off aims to increase shareholder value for both companies. 5. Cortigent's Orion system has received FDA Breakthrough Device designation.